METLIFE INC MET
METLIFE INC is a life insurance issuer listed as MET on NYSE. This free Atlas page links SEC CIK 1099219, Nasdaq Trader and TradingView NYSE:MET, related symbols and the workstation route before a full report is run.
MET public profile
Life insurance issuer. Atlas tracks MET through its NYSE listing record, chart route and source links.
MET trades on NYSE. SEC CIK 1099219. Chart route NYSE:MET.
Nasdaq Trader is the listing identity source for METLIFE INC. Atlas files MET under USA Stocks for browsing. The canonical public URL is /stocks/MET/. The workstation link below opens the fuller research run.
Market Wit preview
MetLife's latest parsed quarter is not short of heft: $743.21B of assets, $715.41B of liabilities, $27.32B of parent equity and $22.69B of cash and cash equivalents at 31 March 2026. That is the insurance business in its natural habitat, where the useful question is less whether the logo looks dependable and more whether a giant balance sheet can keep doing ordinary work without becoming a very expensive puzzle. The company also reported $19.07B of revenues, $1.19B of net income attributable to parent and diluted EPS of $1.74 for the same quarter. This is not a tiny growth story wearing a big coat. It is a vast promise machine, paid to make dullness perform under pressure, which is exactly why the dull numbers deserve first billing. (source: SEC...
Run the full workstation report for the complete source rail, saved history, export controls, and the full Market Wit file for MET.
What changed for METLIFE INC today
MetLife’s current source rail opens with fresh SEC filing trail, not a dramatic market rumour: on 18 June 2026, the evidence lists two Form 144 filings and four Form 4 filings for MET through SEC EDGAR. One Form 144 names the account as the Metlife 401(k) Plan Large Cap Equity Index, which makes the event specific, traceable and less mysterious than the usual market whisper machine.
MetLife is an insurance and financial services operating business, so the story sits in promises, premiums, policies, capital and a very large balance sheet. The supplied scout evidence also points to real operating classification, with the 10-Q saying certain products formerly reported in MetLife Holdings were moved to Group Benefits and Retirement and Income Solutions. That matters because segment labels shape how readers compare the business over time.
The latest parsed filed financials are for the 10-Q period ending 31 March 2026. MetLife reported revenues of $19.07B, net income attributable to parent of $1.19B, operating income of $1.63B and diluted EPS of $1.74 on 655.7M diluted weighted average shares. The same filing rail shows assets of $743.21B, liabilities of $715.41B, parent stockholders’ equity of $27.32B, cash and cash equivalents of $22.69B, short-term investments of $4.95B and net cash provided by operating activities of $2.69B.
No chart route or candle data is supplied in the evidence, so this report cannot claim a level, trend line, moving average or intraday move. The market mechanism here is source-led: EDGAR gives the latest public filing trail, the 10-Q supplies the operating and balance-sheet facts, and the 8-Ks document the earnings presentation and preferred stock dividend declarations.
The 15 May 2026 8-K adds capital-distribution context through a news release announcing quarterly dividends on MetLife’s floating rate non-cumulative preferred stock, Series A, and its 5.625% non-cumulative preferred stock, Series E. That does not prove common-equity return policy, but it does show current official action on the preferred-stock rail.
The thinner part of the file is the absence of sourced share-price context, management guidance figures, common-share repurchase detail or external product demand data. The evidence is still useful: it establishes a large, profitable first-quarter filing base, a named earnings-presentation update, segment-reporting movement and fresh securities filing trail, while leaving market reaction and forward operating colour unparsed.
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
Atlas has no approved static OHLC cache attached for MET yet, so the profile renders the verified TradingView chart route directly and keeps the full-chart link as fallback.
Run an Atlas research workflow on MET
FreedomCore Atlas operates research workstation templates for company snapshots, DCF, LBO, KYC, NAV tie-outs, and council-grade equity briefs. Each workflow uses public-source filings and structured prompts.
Open Atlas workstation ->Save MET research and exports
Free Atlas users can run full browser research reports from the workstation. Atlas Pro adds 25 custom runs a day, saved research history, email delivery, PDF/CSV exports, and a 25-symbol watchlist. £12/mo founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
MET FAQ
What is METLIFE INC (MET)?METLIFE INC is a life insurance issuer listed as MET on NYSE. This free Atlas page links SEC CIK 1099219, Nasdaq Trader and TradingView NYSE:MET, related symbols and...
METLIFE INC is a life insurance issuer listed as MET on NYSE. This free Atlas page links SEC CIK 1099219, Nasdaq Trader and TradingView NYSE:MET, related symbols and the workstation route before a full report is run.
What does Atlas show for MET?The MET page gives the free Atlas profile for METLIFE INC: listing identity, chart route, related symbols, source authority and the workstation route. The chart route...
The MET page gives the free Atlas profile for METLIFE INC: listing identity, chart route, related symbols, source authority and the workstation route. The chart route is NYSE:MET; the stable page route is /stocks/MET/. Visible source links include SEC EDGAR CIK 1099219, Nasdaq Trader and TradingView NYSE:MET. Atlas files MET under USA Stocks for browsing.
How often is the MET page updated?The /stocks/MET/ URL is stable. Atlas updates the free MET page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or...
The /stocks/MET/ URL is stable. Atlas updates the free MET page when the symbol-universe record, listing identity, source links, chart route, related-symbol links or published public answer changes.
Which sources does Atlas use for MET?For MET, Atlas starts with SEC EDGAR CIK 1099219, Nasdaq Trader and TradingView NYSE:MET. The SEC CIK 1099219 route is the issuer filing anchor. Nasdaq Trader confirms...
For MET, Atlas starts with SEC EDGAR CIK 1099219, Nasdaq Trader and TradingView NYSE:MET. The SEC CIK 1099219 route is the issuer filing anchor. Nasdaq Trader confirms the listed-symbol identity used by the public directory. NYSE:MET is the chart route shown on the free page. Full workstation reports may add fresh filings, issuer documents, holdings, news, macro context or model-reviewed notes when available.
Can Atlas run a full research brief on MET?Yes. The workstation can open MET, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open MET, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this MET page investment advice?No. The MET page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a...
No. The MET page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a buy or sell instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-06-19. Browse FreedomCore Atlas research notes →